Literature DB >> 6392291

Defect in insulin receptor phosphorylation in erythrocytes and fibroblasts associated with severe insulin resistance.

F Grigorescu, J S Flier, C R Kahn.   

Abstract

The insulin receptor is a tyrosine-specific protein kinase. Upon binding of the hormone, the kinase is activated resulting in autophosphorylation of the receptor. This kinase activity has been postulated to be an early step in the transmembrane signaling produced by insulin. To evaluate the physiologic relevance of receptor phosphorylation, we have studied insulin binding and autophosphorylation properties using cells from an individual with a variant of the Type A syndrome of severe insulin resistance and acanthosis nigricans. Erythrocytes and cultured fibroblasts from this individual exhibited normal or near normal 125I-insulin binding. Receptors extracted from erythrocytes with Triton X-100 also exhibited normal 125I-insulin binding and competition curves. Despite this, receptors extracted from both erythrocytes and fibroblasts showed a 50% decrease in insulin-stimulated autophosphorylation. Partially purified receptors from the patient's fibroblasts also exhibited a 40% decrease in their ability to phosphorylate exogenous substrates. These data suggest that the insulin resistance in this syndrome is due to a genetic abnormality which impairs insulin receptor phosphorylation and kinase activity and further support the possible role of receptor phosphorylation and kinase activity in insulin action.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6392291

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Defects in insulin binding and receptor kinase in cells from a woman with type A insulin resistance and from her family.

Authors:  Y Suzuki; N Hashimoto; F Shimada; M Taira; M Mimura; O Nozaki; M Tawata; T Onaya; H Makino; S Yoshida
Journal:  Diabetologia       Date:  1991-02       Impact factor: 10.122

Review 2.  Role of kinases in insulin stimulation of glucose transport.

Authors:  A Klip; A G Douen
Journal:  J Membr Biol       Date:  1989-10       Impact factor: 1.843

Review 3.  The insulin receptor: signalling mechanism and contribution to the pathogenesis of insulin resistance.

Authors:  H U Häring
Journal:  Diabetologia       Date:  1991-12       Impact factor: 10.122

4.  Tyrosine kinase activity of liver insulin receptor is inhibited in rats at term gestation.

Authors:  C Martínez; P Ruiz; A Andrés; J Satrústegui; J M Carrascosa
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

5.  Antibodies to insulin receptor tyrosine kinase stimulate its activity towards exogenous substrates without inducing receptor autophosphorylation.

Authors:  V Baron; N Gautier; N Rochet; R Ballotti; B Rossi; S Saint-Pierre; E Van Obberghen; J Dolais-Kitabgi
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

6.  Binding specificity and intramolecular signal transmission of uncleaved insulin proreceptor in transformed lymphocytes from a patient with extreme insulin resistance.

Authors:  T Sasaoka; Y Shigeta; Y Takata; M Sugibayashi; A Hisatomi; M Kobayashi
Journal:  Diabetologia       Date:  1989-06       Impact factor: 10.122

7.  Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity.

Authors:  J F Caro; O Ittoop; W J Pories; D Meelheim; E G Flickinger; F Thomas; M Jenquin; J F Silverman; P G Khazanie; M K Sinha
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

Review 8.  Insulin receptors: structure and function.

Authors:  E Van Obberghen; S Gammeltoft
Journal:  Experientia       Date:  1986-07-15

Review 9.  The insulin receptor concept and its relation to the treatment of diabetes.

Authors:  G M Ward
Journal:  Drugs       Date:  1987-02       Impact factor: 9.546

10.  Tyrosine kinase activity of insulin receptors from an insulin-resistant patient with leprechaunism.

Authors:  A Cama; S I Taylor
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.